PEDRO: A Peer-to-Peer Support Platform for Adverse Drug Reaction Management in Patients with CLL.

Chronic Lymphocytic Leukemia (CLL) treatment often leads to adverse drug reactions (ADRs) and drug-drug interactions (DDIs), significantly impacting patients' quality of life (QoL). To address the challenges in managing ADRs/DDIs, the PEDRO platform was developed to enhance communication between healthcare professionals (HCPs) managing patients with CLL in real-world healthcare settings and experts with significant research profiles in CLL. This paper presents the PEDRO platform built to provide a secure, scalable, and user-friendly solution for peer-to-peer (P2P) support in ADR/DDI management.